Data as of Nov 26
| +0.15 / +1.05%|
The 6 analysts offering 12-month price forecasts for Insmed Inc have a median target of 27.50, with a high estimate of 51.00 and a low estimate of 20.00. The median estimate represents a +91.10% increase from the last price of 14.39.
The current consensus among 6 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.